So there we were, watching the vice presidential debate, wincing at the interruptions and laughing at the memes—and then, out of nowhere, came The Fly. The Fly settled into Mike Pence’s coiffed, icy hair and just…hung out for a while. Pence talked. And Pence talked. And Pence talked some more. And the fly just…chilled. It… Read More »
Despite all its bad news, 2020 has been a good year for burgeoning healthcare companies that have capitalized on the meteoric rise of shell companies pouring billions of dollars into taking them public. This year’s market uncertainty, among other factors, has prompted an explosion in initial public offerings among so-called special purpose acquisition corporations, companies… Read More »
Human burial with incised ceramic at the archaeological site of Bacanga at Sao Luas Island. Credit: André Colonese An international study led by the Institute of Environmental Science and Technology (ICTA-UAB) and the Department of Prehistory at the UAB has reconstructed the diets of pre-Columbian groups on the Amazon coast of Brazil, showing that tropical… Read More »
PRINCETON, N.J.–(BUSINESS WIRE) October 2, 2020 — Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 360 mg every three weeks plus Yervoy (ipilimumab) 1 mg/kg every six weeks (injections for intravenous use) was approved by the U.S. Food and Drug Administration (FDA) for the first-line treatment of adult patients with unresectable malignant pleural… Read More »